NASDAQ:QUCY Mainz Biomed Q4 2025 Earnings Results & Report $1.10 +0.07 (+6.31%) As of 12:12 PM Eastern This is a fair market value price provided by Massive. Learn more. Mainz Biomed reported Q4 2025 earnings on March 31, 2026. The company reported EPS of -$0.0250, while revenue was $0.13 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateMarch 31, 2026TimeAfter Market Closes Mainz Biomed EPS ResultsActual EPS-$0.0250Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AMainz Biomed Revenue ResultsActual Revenue$0.13 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Mainz Biomed Q4 2025 Earnings FAQ Did Mainz Biomed beat earnings estimates for Q4 2025? Mainz Biomed (NASDAQ:QUCY) reported earnings of -$0.0250 per share for Q4 2025. The report was announced on Tuesday, March 31, 2026. What was Mainz Biomed's revenue for Q4 2025? Mainz Biomed reported revenue of $0.13 million for Q4 2025. Mainz Biomed Earnings HeadlinesQuantum Cyber Appoints Major General (Ret.) Alberto C.October 13 at 7:30 AM | globenewswire.comQuantum Cyber Files Audited and Reviewed Financial Statements and Pro Forma Financial Information for Bridgeport Manufacturing AcquisitionSeptember 28, 2026 | globenewswire.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 15 at 1:00 AM | Altimetry (Ad)Quantum Cyber Sharpens Strategic Focus to Quantum Navigation, Interceptor Drones, and U.S. Manufacturing, and Presents New Corporate Investor PresentationSeptember 25, 2026 | globenewswire.comQuantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating SystemSeptember 8, 2026 | globenewswire.comQuantum Cyber NV (QUCY)September 4, 2026 | ru.investing.comSee More Mainz Biomed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Mainz Biomed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mainz Biomed and other key companies, straight to your email. Email Address About Mainz BiomedMainz Biomed (NASDAQ:QUCY) N.V. (NASDAQ: QUCY) is a molecular diagnostics company focused on developing and commercializing noninvasive screening solutions for cancer and other diseases. The company was founded in 2016 and is headquartered in Mainz, Germany. Its principal product is ColoAlert, a stool-based molecular diagnostic test designed to screen for colorectal cancer by analyzing stool samples for genetic biomarkers associated with the disease. The test is intended to provide a convenient, noninvasive alternative to certain conventional screening methods and has been marketed in Germany and other European markets. Mainz Biomed has also pursued regulatory and clinical development activities for the product in the United States. Mainz Biomed’s operations center on the research, development, regulatory advancement, and commercialization of molecular diagnostic products. The company’s leadership has included Guido Baechler as chief executive officer. Its geographic focus has included Europe and the United States, with expansion dependent on applicable regulatory approvals and market access.View Mainz Biomed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling?UnitedHealth Beats on Earnings, But Investors Question Growth PathIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
